Get the Stockscreener App
1.89
1.05%
-0.02
Aethlon Medical Inc stock is traded at $1.89, with a volume of 85,748.
It is down -1.05% in the last 24 hours and down -7.35% over the past month.
Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.
See More
Previous Close:
$1.91
Open:
$1.92
24h Volume:
85,748
Relative Volume:
0.16
Market Cap:
$4.48M
Revenue:
$574.20K
Net Income/Loss:
$-11.52M
P/E Ratio:
-0.0412
EPS:
-45.8332
Net Cash Flow:
$-6.92M
1W Performance:
-0.53%
1M Performance:
-7.35%
6M Performance:
-33.22%
1Y Performance:
+8.62%
1-Day Range:
$1.84
$1.96
1-Week Range:
$1.84
$2.1299
52-Week Range:
$0.5079
$5.89
Aethlon Medical Inc Stock (AEMD) Company Profile
Name
Aethlon Medical Inc
Sector
Industry
Phone
619-941-0360
Address
11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA
Compare AEMD vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AEMD
Aethlon Medical Inc
|
1.89 | 4.48M | 574.20K | -11.52M | -6.92M | -45.83 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Aethlon Medical Inc Stock (AEMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-25 | Resumed | H.C. Wainwright | Neutral |
Aethlon Medical Inc Stock (AEMD) Latest News
Aethlon Medical Inc (AEMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Aethlon Medical Inc (AEMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Aethlon Medical Inc (AEMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aethlon Medical advances Hemopurifier study as final trial cohort nears completion - Proactive financial news
Aethlon Medical Inc (AEMD) Q4 2026 Earnings Call Highlights: Str - GuruFocus
AEMD Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive Stock ReactionCash Flow Report - newsline.com
AEMD Q1 2026 Earnings: Slight EPS Beat Amid Pre-Revenue Status, Stock Gains Over 6%Revenue Estimate Trend - lwvtexas.org
AEMD Q1 2026 Earnings: Narrower-than-Expected Loss Lifts SharesEarnings Volatility Report - newsline.com
Aethlon Medical (AEMD) Reports Q4 2026 Progress in Hemopurifier Trials - GuruFocus
Aethlon Medical Q4 2026 Earnings Call Transcript - MarketBeat
Aethlon outlines cohort 3 expansion to 3–6 patients as Hemopurifier oncology trial advances - MSN
Aethlon Medical FY2026 Earnings: Hemopurifier Advances and Financial OverviewNews and Statistics - IndexBox
Aethlon (AEMD) Q4 2026 Earnings Transcript - The Globe and Mail
Aethlon Medical Reports Fiscal 2026 Results, Clinical Progress - TipRanks
Earnings call transcript: Aethlon Medical Q4 2026 reveals financial strides - Investing.com
AEMD: Operating loss narrowed and clinical milestones achieved as Hemopurifier trials advance - TradingView
Aethlon Medical (AEMD) flags going-concern risk while advancing Hemopurifier trials - Stock Titan
AEMD: Operating expenses fell 21.9% and net loss narrowed as clinical and preclinical programs advanced - TradingView
Aethlon Medical Inc FY 2026: Revenue ($7.17M), Net income ($7.15M), EPS ($10.61) — 10-K Summary - TradingView
Earnings call transcript: Aethlon Medical Q4 2026 reveals financial strides By Investing.com - Investing.com Canada
Q4 2026 Aethlon Medical Inc Earnings Call Transcript - GuruFocus
Aethlon Medical | 8-K: Current report - Moomoo
Net loss narrows at Aethlon Medical (Nasdaq: AEMD) as trials advance - Stock Titan
Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update - TradingView
Earnings Scheduled For June 10, 2026 - Benzinga
AEMD: Operating expenses fell 21.9% and net loss improved to $7.2M as clinical programs advanced - TradingView
AEMD Q4'25 Earnings: EPS estimate is (2.17) USD - TradingView
AEMD Q1 2026 Earnings: Narrower-Than-Expected Loss Amid Continued Pre-Revenue StageEarnings Stability Report - newsline.com
Aethlon Medical (AEMD.US) will release its earnings report after market close on June 10. - Moomoo
AEMD News | AETHLON MEDICAL INC (NASDAQ:AEMD) - ChartMill
Aethlon Medical Updates At-The-Market Equity Offering Capacity - TipRanks
Aethlon Medical raises $542,716 capacity under amended ATM prospectus - TradingView
Aethlon Medical (NASDAQ: AEMD) raises ATM capacity to $542,716 - Stock Titan
AEMD (NASDAQ: AEMD) amends ATM prospectus; $542.7K remaining capacity - Stock Titan
Aethlon Medical (AEMD) to Release Fiscal Year-End Results and Ho - GuruFocus
Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026 - Yahoo Finance Singapore
Hear Aethlon explain its 2026 results: investor Q&A call June 10 - Stock Titan
Aethlon Medical Company Profile & Introduction - Moomoo
Aethlon Medical (AEMD) Plunges 24.83% as Stock Breaks Below Key Support LevelsImpulse Wave - The Legal Advocate
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
AEMD Q1 2026 Earnings: EPS Beats Estimates by 0.75% Amid Revenue Absence, Stock Declines 15.96%EPS Growth Rate - newsline.com
AEMD Stock Pops As Hemopurifier Draws Ebola Outbreak Focus - StocksToTrade
Medical Tech Stock Aethlon Medical (Nasdaq: AEMD) Jumps Amid Escalating Ebola Crisis - Investorideas.com
AEMD Stock Jumps As Hemopurifier Spotlight Returns On Ebola - timothysykes.com
Why Semtech Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket - Benzinga
AEMD Q1 2026 Earnings: Narrower-than-Expected Loss Boosts Investor SentimentCore Business Growth - newsline.com
AEMD Q1 2026 Earnings: Slightly Better Than Expected Loss Amid No RevenueCEO Earnings Statement - newsline.com
AEMD Q1 2026 Earnings: Narrower Slight Loss Surprise Supports Share RecoveryFiscal Year Earnings - Newser
Aethlon Medical (AEMD) Edges Higher, Testing Key Resistance at $2.26Triple EMA - thelegaladvocate.com
Aethlon Medical Inc Stock (AEMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):